Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR | P04035 | 4/20 | 1.00 |
| ▸ | PTPN7 | P35236 | 4/20 | 0.92 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.70 |
| ▸ | RECQL | P46063 | 1/20 | 0.70 |
| ▸ | GPR84 | Q9NQS5 | 6/20 | 0.68 |
| ▸ | PPARG | P37231 | 6/20 | 0.68 |
| ▸ | PPARD | Q03181 | 6/20 | 0.68 |
| ▸ | PPARA | Q07869 | 6/20 | 0.68 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.68 |
| ▸ | TSHR | P16473 | 4/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.68 |
| ▸ | TLR2 | O60603 | 2/20 | 0.68 |
| ▸ | FABP4 | P15090 | 2/20 | 0.68 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.68 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.68 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.68 |
| ▸ | MEN1 | O00255 | 1/20 | 0.68 |
| ▸ | ESR1 | P03372 | 1/20 | 0.68 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.68 |
| ▸ | PDE4A | P27815 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL417934 | 1.00 | HMGCR (1.00) | HMGCRPTPN7TDP1RECQLGPR84 | |
| SCHEMBL3672495 | 1.00 | HMGCR (1.00) | HMGCRPTPN7TDP1RECQLGPR84 | |
| SCHEMBL4236378 | 1.00 | HMGCR (1.00) | HMGCRPTPN7TDP1RECQLGPR84 | |
| SCHEMBL3667270 | 1.00 | HMGCR (1.00) | HMGCRPTPN7TDP1RECQLGPR84 | |
| Arachidic Acid SCHEMBL10942966 | 1.00 | HMGCR (1.00) | HMGCRPTPN7TDP1RECQLGPR84 | |
| SCHEMBL3673938 | 1.00 | HMGCR (1.00) | HMGCRPTPN7TDP1RECQLGPR84 | |
| SCHEMBL455799 | 1.00 | HMGCR (1.00) | HMGCRPTPN7TDP1RECQLGPR84 | |
| SCHEMBL5052818 | 1.00 | HMGCR (1.00) | HMGCRPTPN7TDP1RECQLGPR84 | |
| SCHEMBL12478231 | 1.00 | HMGCR (1.00) | HMGCRPTPN7TDP1RECQLGPR84 | |
| Stearic Acid SCHEMBL10942937 | 1.00 | HMGCR (1.00) | HMGCRPTPN7TDP1RECQLGPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260055280-A1 | RADIATION SENSITIVE COMPOSITIONS COMPRISING A COMBINATION OF METALS OR METALLOID COMPOUNDS | ISP INVESTMENTS LLC (US) | 2026-02-26 | — | — | US | claimed |
| US-20250347642-A1 | TEMPERATURE IMAGING DEVICE AND METHOD FOR MANUFACTURING SAME | KEIO UNIVERSITY (JP) | 2025-11-13 | — | — | US | claimed |
| EP-4634647-A1 | CORE-SHELL MICROPARTICLES FOR COLORIMETRIC SENSING AND METHODS FOR MAKING AND USING THE SAME | Trustees of Tufts College (US) | 2025-10-22 | — | — | EP | claimed |
| EP-4610652-A1 | YAXAB NANOPORE, NANOPORE SYSTEM COMPRISING SAME AND APPLICATIONS THEREOF | Korea Research Institute of Bioscience and Biotechnology (KR) | 2025-09-03 | — | — | EP | claimed |
| US-20250189683-A1 | RADIATION SENSITIVE FILMS HAVING HIGH RADIATION SENSITIVITIES | ISP INVESTMENTS LLC (US) | 2025-06-12 | — | — | US | claimed |
| EP-4534003-A1 | TEMPERATURE IMAGING DEVICE AND METHOD FOR MANUFACTURING SAME | Keio University (JP) | 2025-04-09 | — | — | EP | claimed |
| US-20240423976-A1 | COMPOSITIONS AND METHODS FOR TREATING THERAPEUTIC-INDUCED TOXICITIES | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 2024-12-26 | — | — | US | claimed |
| EP-4416552-A1 | RADIATION SENSITIVE COMPOSITIONS COMPRISING A COMBINATION OF METALS OR METALLOID COMPOUNDS | ISP Investments LLC (US) | 2024-08-21 | — | — | EP | claimed |
| WO-2024129873-A1 | CORE-SHELL MICROPARTICLES FOR COLORIMETRIC SENSING AND METHODS FOR MAKING AND USING THE SAME | TRUSTEES OF TUFTS COLLEGE (US) | 2024-06-20 | — | — | WO | claimed |
| WO-2024090998-A1 | YAXAB NANOPORE, NANOPORE SYSTEM COMPRISING SAME AND APPLICATIONS THEREOF | 한국생명공학연구원 | 2024-05-02 | — | — | WO | claimed |
| EP-0293466-A1 | IMPROVING SENSITIVITY OF PROCESSLESS RECORDING MEDIA | GAF CHEMICALS CORPORATION (US) | 1988-12-07 | — | — | EP | claimed |
| EP-0293463-A1 | RECORDING MEDIUM OF IMPROVED STABILITY | GAF CHEMICALS CORPORATION (US) | 1988-12-07 | — | — | EP | claimed |
| WO-1988004792-A1 | RECORDING MEDIUM OF IMPROVED STABILITY | GAF CORPORATION (US) | 1988-06-30 | — | — | WO | claimed |
| WO-1988004793-A1 | IMPROVING SENSITIVITY OF PROCESSLESS RECORDING MEDIA | GAF CORPORATION (US) | 1988-06-30 | — | — | WO | claimed |
| US-4734355-A | DISPERSION OF MICROCRYSTALS OF DI-YNE IN NON-SOLVATING LIQUID | GAF CORPORATION (US) | 1988-03-29 | — | — | US | claimed |
| US-4705742-A | Processless multicolor imaging | GAF CORPORATION (US) | 1987-11-10 | — | — | US | claimed |
| EP-0239580-A1 | PROCESSLESS MULTICOLOR IMAGING | GAF CORPORATION (US) | 1987-10-07 | — | — | EP | claimed |
| US-4698296-A | MULTILAYER, MULTICOLOR | GAF CORPORATION (US) | 1987-10-06 | — | — | US | claimed |
| WO-1987005717-A1 | PROCESSLESS COLOR IMAGING AND FILM THEREFOR | GAF CORPORATION (US) | 1987-09-24 | — | — | WO | claimed |
| WO-1987001825-A1 | PROCESSLESS MULTICOLOR IMAGING | GAF CORPORATION (US) | 1987-03-26 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260055280-A1 | RADIATION SENSITIVE COMPOSITIONS COMPRISING A COMBINATION OF METALS OR METALLOID COMPOUNDS | BRCA1, ATR, ATM | HMGCR 1408/4885PTPN7 2525/4885TDP1 2348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.